Literature DB >> 28607066

Socioeconomic disadvantage, gestational immune activity, and neurodevelopment in early childhood.

Stephen E Gilman1,2,3, Mady Hornig4,5, Akhgar Ghassabian6, Jill Hahn2, Sara Cherkerzian7,8, Paul S Albert9, Stephen L Buka10, Jill M Goldstein7,8,11,12.   

Abstract

Children raised in economically disadvantaged households face increased risks of poor health in adulthood, suggesting that inequalities in health have early origins. From the child's perspective, exposure to economic hardship may begin as early as conception, potentially via maternal neuroendocrine-immune responses to prenatal stressors, which adversely impact neurodevelopment. Here we investigate whether socioeconomic disadvantage is associated with gestational immune activity and whether such activity is associated with abnormalities among offspring during infancy. We analyzed concentrations of five immune markers (IL-1β, IL-6, IL-8, IL-10, and TNF-α) in maternal serum from 1,494 participants in the New England Family Study in relation to the level of maternal socioeconomic disadvantage and their involvement in offspring neurologic abnormalities at 4 mo and 1 y of age. Median concentrations of IL-8 were lower in the most disadvantaged pregnancies [-1.53 log(pg/mL); 95% CI: -1.81, -1.25]. Offspring of these pregnancies had significantly higher risk of neurologic abnormalities at 4 mo [odds ratio (OR) = 4.61; CI = 2.84, 7.48] and 1 y (OR = 2.05; CI = 1.08, 3.90). This higher risk was accounted for in part by fetal exposure to lower maternal IL-8, which also predicted higher risks of neurologic abnormalities at 4 mo (OR = 7.67; CI = 4.05, 14.49) and 1 y (OR = 2.92; CI = 1.46, 5.87). Findings support the role of maternal immune activity in fetal neurodevelopment, exacerbated in part by socioeconomic disadvantage. This finding reveals a potential pathophysiologic pathway involved in the intergenerational transmission of socioeconomic inequalities in health.

Entities:  

Keywords:  epidemiology; gestation; inflammation; neurodevelopment; socioeconomic disadvantage

Mesh:

Substances:

Year:  2017        PMID: 28607066      PMCID: PMC5495226          DOI: 10.1073/pnas.1617698114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

2.  The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation.

Authors:  Mary E Coussons-Read; Marci Lobel; J Chris Carey; Marianne O Kreither; Kimberly D'Anna; Laura Argys; Randall G Ross; Chandra Brandt; Stephanie Cole
Journal:  Brain Behav Immun       Date:  2012-03-07       Impact factor: 7.217

Review 3.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

4.  Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.

Authors:  B H Yoon; R Romero; J S Park; C J Kim; S H Kim; J H Choi; T R Han
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

Review 5.  Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?

Authors:  Nicole M Talge; Charles Neal; Vivette Glover
Journal:  J Child Psychol Psychiatry       Date:  2007 Mar-Apr       Impact factor: 8.982

6.  Psychoneuroimmunology in pregnancy: immune pathways linking stress with maternal health, adverse birth outcomes, and fetal development.

Authors:  Lisa M Christian
Journal:  Neurosci Biobehav Rev       Date:  2011-07-19       Impact factor: 8.989

Review 7.  The effects of maternal inflammation on neuronal development: possible mechanisms.

Authors:  G Miller Jonakait
Journal:  Int J Dev Neurosci       Date:  2007-09-14       Impact factor: 2.457

8.  Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta.

Authors:  Fiona C Denison; Sharon Battersby; Anne E King; Michael Szuber; Henry N Jabbour
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

9.  Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.

Authors:  David Maldonado-Pérez; Pamela Brown; Kevin Morgan; Robert P Millar; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-04-05

10.  Elevated maternal C-reactive protein and autism in a national birth cohort.

Authors:  A S Brown; A Sourander; S Hinkka-Yli-Salomäki; I W McKeague; J Sundvall; H-M Surcel
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

View more
  26 in total

1.  Association of the World War II Finnish Evacuation of Children With Psychiatric Hospitalization in the Next Generation.

Authors:  Torsten Santavirta; Nina Santavirta; Stephen E Gilman
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

2.  Antenatal and Neonatal Antecedents of Executive Dysfunctions in Extremely Preterm Children.

Authors:  Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; H Gerry Taylor; Karl K C Kuban
Journal:  J Child Neurol       Date:  2018-01-11       Impact factor: 1.987

Review 3.  Inflammation: A Proposed Intermediary Between Maternal Stress and Offspring Neuropsychiatric Risk.

Authors:  Liisa Hantsoo; Sara Kornfield; Montserrat C Anguera; C Neill Epperson
Journal:  Biol Psychiatry       Date:  2018-09-05       Impact factor: 13.382

4.  Maternal Immune activity during pregnancy and socioeconomic disparities in children's self-regulation.

Authors:  Jing Yu; Akhgar Ghassabian; Zhen Chen; Risë B Goldstein; Mady Hornig; Stephen L Buka; Jill M Goldstein; Stephen E Gilman
Journal:  Brain Behav Immun       Date:  2020-09-10       Impact factor: 7.217

5.  Gestational Cytokines and the Developmental Expression of Obesity in Childhood.

Authors:  Akhgar Ghassabian; Mady Hornig; Zhen Chen; Edwina Yeung; Stephen L Buka; Jing Yu; Gina Ma; Jill M Goldstein; Stephen E Gilman
Journal:  Obesity (Silver Spring)       Date:  2020-09-27       Impact factor: 5.002

6.  Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.

Authors:  Mikhail G Dozmorov; Staci D Bilbo; Scott H Kollins; Nancy Zucker; Elizabeth K Do; Julia C Schechter; Junfeng Jim Zhang; Susan K Murphy; Cathrine Hoyo; Bernard F Fuemmeler
Journal:  Brain Behav Immun       Date:  2018-03-26       Impact factor: 7.217

7.  Maternal Bacterial Infection During Pregnancy and Offspring Risk of Psychotic Disorders: Variation by Severity of Infection and Offspring Sex.

Authors:  Younga H Lee; Sara Cherkerzian; Larry J Seidman; George D Papandonatos; David A Savitz; Ming T Tsuang; Jill M Goldstein; Stephen L Buka
Journal:  Am J Psychiatry       Date:  2019-10-04       Impact factor: 18.112

8.  A Bayesian regularized mediation analysis with multiple exposures.

Authors:  Yu-Bo Wang; Zhen Chen; Jill M Goldstein; Germaine M Buck Louis; Stephen E Gilman
Journal:  Stat Med       Date:  2018-10-29       Impact factor: 2.373

Review 9.  Teeth as Potential New Tools to Measure Early-Life Adversity and Subsequent Mental Health Risk: An Interdisciplinary Review and Conceptual Model.

Authors:  Kathryn A Davis; Rebecca V Mountain; Olivia R Pickett; Pamela K Den Besten; Felicitas B Bidlack; Erin C Dunn
Journal:  Biol Psychiatry       Date:  2019-12-17       Impact factor: 13.382

Review 10.  Sex differences in major depression and comorbidity of cardiometabolic disorders: impact of prenatal stress and immune exposures.

Authors:  Jill M Goldstein; Taben Hale; Simmie L Foster; Stuart A Tobet; Robert J Handa
Journal:  Neuropsychopharmacology       Date:  2018-07-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.